Cybin to Participate in the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6, 2021

Rhea-AI Summary

Cybin is set to participate in the 2nd Annual H.C. Wainwright Psychedelics Conference on December 6, 2021. CEO Doug Drysdale will engage in a fireside chat available on demand starting at 7:00 a.m. ET. Interested listeners can access the chat and the archived webcast through Cybin's investor relations website. Founded in 2019 and headquartered in Canada, Cybin focuses on developing safe therapeutics to address mental health issues using its unique drug discovery platforms.

TORONTO--(BUSINESS WIRE)-- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics^TM” is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will participate in a fireside chat at the 2^nd Annual H.C. Wainwright Psychedelics Conference being held virtually on Monday, December 6, 2021.

Mr. Drysdale’s fireside chat will be available on demand beginning on December 6, 2021 at 7:00 a.m. ET. To listen to the event, please click here to access the webcast. The archived webcast will also be available on the Company’s investor relations website on the Events & Presentations page.

About Cybin
Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in the United States, United Kingdom and Ireland. The Company is focused on progressing Psychedelics to Therapeutics^TM by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211129005658/en/

Investor & Media:

Leah Gibson

Vice President, Investor Relations

Cybin Inc.

leah@cybin.com

Source: Cybin Inc.

FAQ

When will Cybin's CEO Doug Drysdale speak at the H.C. Wainwright Psychedelics Conference?

Doug Drysdale will participate in the conference on December 6, 2021.

How can I access the on-demand fireside chat with Doug Drysdale?

The chat will be available on demand starting at 7:00 a.m. ET on December 6, 2021, and can be accessed through the company's website.

What is Cybin's focus as a biopharmaceutical company?

Cybin focuses on developing safe and effective therapeutics for mental health issues using psychedelics.

Where is Cybin headquartered?

Cybin is headquartered in Canada.

What year was Cybin founded?

Cybin was founded in 2019.